Calidi Biotherapeutics Debt to Equity Ratio Trends

Calidi Biotherapeutics Inc (CLDI)

0.195 0.00 (0.00%) USD | NYAM | May 02, 16:00

0.195 0.00 (0.00%) After-Hours: 16:28

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2021	-0.1582

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

-0.1582

Minimum

Dec 2021

-0.1582

Maximum

Dec 2021

-0.1582

Average

-0.1582

Median

Dec 2021

Debt to Equity Ratio Benchmarks

Minerva Neurosciences Inc	--
Viking Therapeutics Inc	--
Regenxbio Inc	0.00
CytomX Therapeutics Inc	0.00
Janux Therapeutics Inc	0.00

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	10.02M
Total Liabilities (Quarterly)	18.25M
Shareholders Equity (Quarterly)	-8.235M